SE0303268D0 - Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof - Google Patents

Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof

Info

Publication number
SE0303268D0
SE0303268D0 SE0303268A SE0303268A SE0303268D0 SE 0303268 D0 SE0303268 D0 SE 0303268D0 SE 0303268 A SE0303268 A SE 0303268A SE 0303268 A SE0303268 A SE 0303268A SE 0303268 D0 SE0303268 D0 SE 0303268D0
Authority
SE
Sweden
Prior art keywords
methods
angiogenesis
compositions
proteins
relates
Prior art date
Application number
SE0303268A
Other languages
English (en)
Inventor
Mats Hellstroem
Elisabet Wallgard
Mattias Kalen
Original Assignee
Angiogenetics Sweden Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angiogenetics Sweden Ab filed Critical Angiogenetics Sweden Ab
Priority to SE0303268A priority Critical patent/SE0303268D0/sv
Publication of SE0303268D0 publication Critical patent/SE0303268D0/sv
Priority to EP04801722A priority patent/EP1699818A2/en
Priority to NZ577564A priority patent/NZ577564A/en
Priority to PCT/SE2004/001814 priority patent/WO2005054426A2/en
Priority to AU2004295654A priority patent/AU2004295654A1/en
Priority to NZ547877A priority patent/NZ547877A/xx
Priority to US10/581,761 priority patent/US20090036362A1/en
Priority to JP2006542541A priority patent/JP2007512835A/ja
Priority to CA002548208A priority patent/CA2548208A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/515—Angiogenesic factors; Angiogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/05—Animals modified by non-integrating nucleic acids, e.g. antisense, RNAi, morpholino, episomal vector, for non-therapeutic purpose
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/40—Fish
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0375—Animal model for cardiovascular diseases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SE0303268A 2003-12-05 2003-12-05 Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof SE0303268D0 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE0303268A SE0303268D0 (sv) 2003-12-05 2003-12-05 Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof
EP04801722A EP1699818A2 (en) 2003-12-05 2004-12-06 Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use
NZ577564A NZ577564A (en) 2003-12-05 2004-12-06 Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof
PCT/SE2004/001814 WO2005054426A2 (en) 2003-12-05 2004-12-06 Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof
AU2004295654A AU2004295654A1 (en) 2003-12-05 2004-12-06 Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof
NZ547877A NZ547877A (en) 2003-12-05 2004-12-06 Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof
US10/581,761 US20090036362A1 (en) 2003-12-05 2004-12-06 Angiogenesis Affecting Polypeptides, Proteins, and Composition, and Methods of Use Thereof
JP2006542541A JP2007512835A (ja) 2003-12-05 2004-12-06 新脈管形成に影響を与えるポリペプチド、タンパク質及び組成物、及びそれを使用する方法
CA002548208A CA2548208A1 (en) 2003-12-05 2004-12-06 Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0303268A SE0303268D0 (sv) 2003-12-05 2003-12-05 Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof

Publications (1)

Publication Number Publication Date
SE0303268D0 true SE0303268D0 (sv) 2003-12-05

Family

ID=29778161

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0303268A SE0303268D0 (sv) 2003-12-05 2003-12-05 Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof

Country Status (2)

Country Link
US (1) US20090036362A1 (sv)
SE (1) SE0303268D0 (sv)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602307A (en) * 1992-08-12 1997-02-11 Baylor College Of Medicine Non-human animal having predefined allele of a cellular adhesion gene
US5489743A (en) * 1993-01-19 1996-02-06 Amgen Inc. Transgenic animal models for thrombocytopenia
US6242179B1 (en) * 1997-12-17 2001-06-05 Incyte Pharmaceuticals, Inc. Human phosphatases
US20030203843A1 (en) * 2001-04-20 2003-10-30 Pena Carol E. A. Proteins and nucleic acids encoding same
US7250495B2 (en) * 2001-06-20 2007-07-31 Genentech, Inc. PRO20044 polypeptides
AU2003295328A1 (en) * 2002-10-02 2004-04-23 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
JP3924306B2 (ja) * 2005-07-20 2007-06-06 インターナショナル・ビジネス・マシーンズ・コーポレーション ソフトウェア・パッケージを再構築する方法

Also Published As

Publication number Publication date
US20090036362A1 (en) 2009-02-05

Similar Documents

Publication Publication Date Title
ATE269402T1 (de) Ikk-beta proteine, nukleinsäuren und verfahren
DK1641818T3 (da) Polypeptider der har bindingsaffinitet for HER2
NZ763572A (en) Trispecific proteins and methods of use
CY1115188T1 (el) Πολυκυκλικες ετεροαρυλ-υποκατεστημενες τριαζολες χρησιμες ως αναστολεις του axl
FR16C0021I2 (fr) Azetidines en tant qu'inhibiteurs de mek et leur utilisation pour le traitement des maladies proliferatives
HUP0401591A2 (hu) Új receptor-nukleinsavak és- polipeptidek
CY1115357T1 (el) Χρηση αναστολεων πεπτιδιου του μονοπατιου μεταγωγης σηματος jnk οι οποιοι διαπερνουν τα κυτταρα για τη θεραπευτικη αγωγη διαφορων νοσηματων
WO2004076639A3 (en) Use of gene expression profiling in the diagnosis and treatment of lupus nephritis and systemic lupus erythematosus
NO20082559L (no) Humane monoklonale antistoffer mot protein tyrosin kinase 7 (PTK7) og fremgangsmater for anvendelse av anti-PTK7 antistoffer
ATE506951T1 (de) Als inhibitoren von beta-secretase aktive tertiäre carbinamine mit substituierten heterocyclen zur behandlung der alzheimer- krankheit
TW200636076A (en) Method for measuring resistance or sensitivity to docetaxel
ATE421589T1 (de) Optisches abbildungssystem zur darstellung der genexpression des gesamten körpers und anwendungen
DE602005023887D1 (de) Als b-sekretase (bace)-hemmer nützliche 2-amino-chinazolinderivate
DE602004016499D1 (de) Zusammensetzungen und verfahren zur behandlung von entzündlicher darmerkrankung
ATE500265T1 (de) Synthetische mecp2-sequenz für die proteinersatztherapie
WO2002088750A3 (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
ATE543833T1 (de) Bmp-7-varianten-zusammensetzungen, verfahren und verwendungen
NO20052956D0 (no) Defensinprotiner
RS20050577A (en) Compositions and methods for treating cancer using igsf9 and liv-1
NO20021146D0 (no) Polymorfier i de humane CYP3A4- og CYP3A7-genene og deres anvendelse i diagnostiske og terapeutiske anvendelser
ATE247130T1 (de) Inhibitoren für den urokinaserezeptor
WO2005054426A3 (en) Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof
SE0301987D0 (sv) New polypeptide
SE0303268D0 (sv) Angiogenesis affecting polypeptides, proteins, and compositions, and methods of use thereof
DE602005021159D1 (de) Bakteriophagen- und prophagen-proteine in der krebsgentherapie